Cognitive-behavioral therapy for social anxiety disorder: Current status and future directions

Biological Psychiatry

Volumn 51, Issue 1, 2002, Pages 101-108

  Heimberg, Richard G ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

Anxiety disorders; Cognitive behavioral therapy; Empirically supported treatment; Psychosocial treatment; Social anxiety disorder; Social phobia

Indexed keywords

ALPRAZOLAM; ATENOLOL; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CLONAZEPAM; FLUOXETINE; MONOAMINE OXIDASE INHIBITOR; PHENELZINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ANXIETY NEUROSIS; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; COMPARATIVE STUDY; DRUG EFFICACY; FOLLOW UP; HUMAN; META ANALYSIS; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RELAXATION TRAINING; SOCIAL ADAPTATION; SOCIAL PHOBIA; TREATMENT OUTCOME;

EID: 0036153311     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01183-0     Document Type: Review

References (62)

1. Alprazolam and exposure for panic disorder with agoraphobia: Attribution of improvement to medication predicts subsequent relapse
2. Social phobia subtype and avoidant personality disorder: Effect on severity of social phobia, impairment, and outcome of cognitive behavioral treatment
3. Comorbidity among anxiety disorders: Implications for treatment and DSM-IV
4. Predictors of response to cognitive-behavioral group therapy for social phobia
5. The assessment and treatment of performance anxiety in musicians
6. A cognitive model of social phobia
7. Adherence during sessions and homework in cognitive-behavioral group treatment of social phobia
8. National Institute of Mental Health Treatment of Depression Collaborative Research Program: General effectiveness of treatments
9. Quality of life following cognitive behavioral treatment for social anxiety disorder: Preliminary findings
10. Cormorbid mood and anxiety disorders among persons with social anxiety disorder
11. The treatment of social phobia: Real-life rehearsal with nonprofessional therapists
12. Psychological and pharmacological treatments for social phobia: A meta-analysis
13. Cognitive behavioral versus exposure only treatment for social phobia: A meta-analysis
14. Avoidant personality disorder as a predictor for severity and treatment outcome among generalized social phobics
15. Emotional processing of fear: Exposure to corrective information
16. Social and specific phobias
17. Clinical validation of the quality of life inventory: A measure of life satisfaction for use in treatment planning and outcome assessment
18. Psychodynamics of panic disorder and social phobia
19. Cognitive-behavioral and pharmacological treatments of social phobia: A controlled study
20. The behavioral assessment of male and female social competence in dyadic heterosexual interactions
21. Cognitive-behavoiral and pharmacological treatment for social phobia: A meta-analysis
22. Cognitive and social skills correlates of social anxiety
23. Social phobia, avoidant personality disorder and the multiaxial conceptualization of interpersonal anxiety
24. Cognitive behavioral group treatment for social phobia: Comparison with a credible placebo control
25. Cognitive-behavioral group treatment: Description, case presentation, and empirical support
26. Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome
27. Cognitive behavioral group treatment for social phobia: Effectiveness at five-year follow-up
28. Dismantling cognitive-behavioral group therapy for social phobia
29. Diagnostic subtype, avoidant personality disorder, and efficacy of cognitive-behavioral group therapy for social phobia
30. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey
31. Homework compliance, perceptions of control, and outcome of cognitive-behavioral treatment of social phobia
32. Cognitive-behavioral group therapy versus phenelzine in social phobia: Long-term outcome
33. Open trial of interpersonal psychotherapy for the treatment of social phobia
34. Psychotherapy of dysthymia
35. Applied relaxation: Description of a coping technique and review of controlled studies
36. A comparison of the efficacy of clonazepam and cognitive-behavioral group therapy for the treatment of social phobia
37. Discontinuation of benzodiazepine treatment: Efficacy of cognitive-behavioral therapy for patients with panic disorder
38. A cognitive-behavioral model of anxiety in social phobia
39. Discrepancy between self- and observer ratings of performance in social phobics
40. Quality of life in social phobia
41. Clients' expectancies and their relationship to pretreatment symptomatology and outcome of cognitive-behavioral group treatment for social phobia
42. Benzodiazepines and behavioral treatment of phobic anxiety
43. Social phobia: Comorbidity and morbidity in an epidemiologic sample
44. The relationship of social phobia subtypes and avoidant personality disorder
45. Disability and quality of life in social phobia: Epidemiologic findings
46. Cognitive processes in social phobia
47. Meta-analysis of cognitive-behavioral treatment for social phobia
48. Cognitive behavior therapy
49. A multicomponent behavioral treatment for social phobia: Social effectiveness therapy
50. Social phobia: A comparison of behavior therapy and atenolol
51. Clinical features affecting treatment outcome in social phobia
52. The impact of personality disorders on behavioral treatment outcome for social phobia
53. Social phobia: The role of in-situation safety behaviors in maintaining anxiety and negative beliefs
54. Social phobia: Effects of external attention on anxiety, negative beliefs, and perspective taking
55. Generalized social phobia versus avoidant personality disorder: A commentary on three studies
56. Group cognitive-behavioral therapy and group interpersonal psychotherapy for the nonpurging bulimic individual: A controlled comparison